These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7697845)

  • 1. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty.
    Minar E; Ahmadi A; Koppensteiner R; Maca T; Stümpflen A; Ugurluoglu A; Ehringer H
    Circulation; 1995 Apr; 91(8):2167-73. PubMed ID: 7697845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: a retrospective chart review in Japanese patients.
    Ishii H; Kumada Y; Toriyama T; Aoyama T; Takahashi H; Tanaka M; Kamoi D; Kawamura Y; Yamada S; Hayashi M; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Clin Ther; 2010 Jan; 32(1):24-33. PubMed ID: 20171408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries.
    Karch LA; Mattos MA; Henretta JP; McLafferty RB; Ramsey DE; Hodgson KJ
    J Vasc Surg; 2000 May; 31(5):880-7. PubMed ID: 10805877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
    Dake MD; Ansel GM; Jaff MR; Ohki T; Saxon RR; Smouse HB; Machan LS; Snyder SA; O'Leary EE; Ragheb AO; Zeller T;
    Circulation; 2016 Apr; 133(15):1472-83; discussion 1483. PubMed ID: 26969758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of failure of endovascular therapy for peripheral arterial disease.
    Yacyshyn VJ; Thatipelli MR; Lennon RJ; Bailey KR; Stanson AW; Holmes DR; Gloviczki P
    Angiology; 2006; 57(4):403-17. PubMed ID: 17022375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
    Gallino A; Do DD; Alerci M; Baumgartner I; Cozzi L; Segatto JM; Bernier J; Tutta P; Kellner F; Triller J; Schneider E; Amann-Vesti B; Studer G; Jäger K; Aschwanden M; Canevascini R; Jacob AL; Kann R; Greiner R; Mahler F
    J Endovasc Ther; 2004 Dec; 11(6):595-604. PubMed ID: 15615549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries.
    Minar E; Ehringer H; Ahmadi R; Dudczak R; Leitha T; Koppensteiner R; Jung M; Stümpflen A
    Radiology; 1989 Mar; 170(3 Pt 1):767-72. PubMed ID: 2521736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study.
    Minar E; Pokrajac B; Maca T; Ahmadi R; Fellner C; Mittlböck M; Seitz W; Wolfram R; Pötter R
    Circulation; 2000 Nov; 102(22):2694-9. PubMed ID: 11094034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transluminal stenting for femoropopliteal occlusive disease: analysis of restenosis by serial arteriography.
    Bui TD; Gordon IL; Nguyen T; Fujitani RM; Wilson SE; Conroy RC
    Ann Vasc Surg; 2006 Mar; 20(2):200-8. PubMed ID: 16555031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results.
    Strecker EP; Boos IB; Göttmann D; Vetter S
    Eur Radiol; 2004 Feb; 14(2):302-8. PubMed ID: 12856136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up.
    Schillinger M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Minar E
    J Endovasc Ther; 2003 Apr; 10(2):288-97. PubMed ID: 12877612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of high- versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease.
    Ranke C; Creutzig A; Luska G; Wagner HH; Galanski M; Bode-Böger S; Frölich J; Avenarius HJ; Hecker H; ALexander K
    Clin Investig; 1994 Sep; 72(9):673-80. PubMed ID: 7849445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
    Conrad MF; Cambria RP; Stone DH; Brewster DC; Kwolek CJ; Watkins MT; Chung TK; LaMuraglia GM
    J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study.
    Minar E; Pokrajac B; Ahmadi R; Maca T; Seitz W; Stümpflen A; Pötter R; Ehringer H
    Radiology; 1998 Jul; 208(1):173-9. PubMed ID: 9646810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
    Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam irradiation and restenosis following femoral stenting: long-term results of a prospective randomized study.
    Zampakis P; Karnabatidis D; Kalogeropoulou C; Kardamakis DM; Katsanos K; Skouras T; Siablis D
    Cardiovasc Intervent Radiol; 2007; 30(3):362-9. PubMed ID: 17295082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.